Cite
HARVARD Citation
Bader-Meunier, B. et al. (2022). Effectiveness and safety of ruxolitinib for the treatment of refractory systemic idiopathic juvenile arthritis like associated with interstitial lung disease : a case report. Annals of the rheumatic diseases. 81 (2), p. e20. [Online].